Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes. (2022)
Attributed to:
Randomised trials in cardiovascular and metabolic disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/sciadv.add5430
PubMed Identifier: 36383675
Publication URI: http://europepmc.org/abstract/MED/36383675
Type: Journal Article/Review
Volume: 8
Parent Publication: Science advances
Issue: 46
ISSN: 2375-2548